Keywords: sanofi-synthelabo, eps, leap, french, drugmaker, reported, net
Sanofi-Synthelabo 2001 EPS leap 44%
Article | 25 February 2002
French drugmaker Sanofi-Synthelabo has reported net profit of 1.58billion euros ($1.37 billion) for 2001, a rise of 61% on the previous year. Net ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
